Patients aged of 18 and over,
Satisfying the 1987 American College of Rheumatology (ACR) criteria for RA
Receiving a prescription of Adalimumab 40 mg subcutaneous every two weeks.

NCT02035800_inc_T1
Person
aged
NCT02035800_inc_T2
Value
18 and over
NCT02035800_inc_T3
Qualifier
1987 American College of Rheumatology (ACR) criteria
NCT02035800_inc_T4
Condition
RA
NCT02035800_inc_T5
Drug
Adalimumab
NCT02035800_inc_T6
Multiplier
 mg  ery two weeks.
NCT02035800_inc_T7
Qualifier
subcutaneous